The challenge of silent rheumatic heart disease

The Lancet Global Health

Volumn 2, Issue 12, 2014, Pages e677-e678

  Mayosi, Bongani M ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE;

DRUG EFFICACY; ECHOCARDIOGRAPHY; HEART AUSCULTATION; HUMAN; INCIDENCE; META ANALYSIS (TOPIC); NOTE; PREVALENCE; RHEUMATIC HEART DISEASE; SYSTEMATIC REVIEW (TOPIC); ADOLESCENT; CHILD; HEALTH; MASS SCREENING;

ADOLESCENT; CHILD; GLOBAL HEALTH; HUMANS; MASS SCREENING; PREVALENCE; RHEUMATIC HEART DISEASE;

EID: 84918833740     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(14)70331-6     Document Type: Note

References (14)

1. Mayosi BM, Gamra H, Dangou J-M, Kasonde J Rheumatic heart disease in Africa: the Mosi-o-Tunya call to action. Lancet Glob Health 2014, 2:e438-e439.
2. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007, 357:470-476.
3. Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S Incidence and characteristics of newly diagnosed rheumatic heart disease in Urban African adults: insights from the Heart of Soweto Study. Eur Heart J 2010, 31:719-727.
4. Lawrence JG, Carapetis JR, Griffiths K, Edwards K, Condon JR Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010. Circulation 2013, 128:492-501.
5. Engel ME, Stander R, Vogel J, Adeyemo AA, Mayosi BM Genetic susceptibility to acute rheumatic fever: a systematic review and meta-analysis of twin studies. PLoS One 2011, 6:e25326.
6. Rothenbühler M, O'Sullivan CJ, Stortecky S, et al. Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. Lancet Glob Health 2014, 2:e717-e726.
7. Brown A, McDonald MI, Calma T Rheumatic fever and social justice. Med J Aust 2007, 186:557-558.
8. McLaren MJ, Hawkins DM, Koornhof HJ, et al. Epidemiology of rheumatic heart disease in black school children of Soweto, Johannesburg. Br Med J 1975, 3:474-478.
9. Kane A, Mirabel M, Touré K, et al. Echocardiographic screening for rheumatic heart disease: age matters. Int J Cardiol 2013, 168:888-891.
10. Carapetis JR, Steer AC, Mulholland EK, Weber M The global burden of group A streptococcal diseases. Lancet Infect Dis 2005, 5:685-694.
11. Omurzakova NA, Yamano Y, Saatova GM, et al. High incidence of rheumatic fever and rheumatic heart disease in the republics of Central Asia. Int J Rheum Dis 2009, 12:79-83.
12. Zuhlke L, Mayosi BM Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis. Curr Cardiol Rep 2013, 15:343.
13. Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
14. Global action plan for the prevention and control of NCDs 2013-2020 2013, WHO, World Health Organization, Geneva.